{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T02:32:11Z","timestamp":1794018731290,"version":"4.8.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T00:00:00Z","timestamp":1598313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.vaccine.2020.08.052","type":"journal-article","created":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T22:06:05Z","timestamp":1598997965000},"page":"6682-6694","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":132,"title":["Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates"],"prefix":"10.1016","volume":"38","author":[{"given":"Fiorella","family":"Bianchi-Jassir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Proma","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ka-Ning","family":"To","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Carreras-Abad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0129-3146","authenticated-orcid":false,"given":"Anna C.","family":"Seale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7075-6896","authenticated-orcid":false,"given":"Elita","family":"Jauneikaite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7629-0636","authenticated-orcid":false,"given":"Shabir A.","family":"Madhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Madrid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quique","family":"Bassat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Kwatra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsty","family":"Le Doare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy E.","family":"Lawn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.08.052_b0005","unstructured":"UNICEF. Inter-agency Group for Child Mortality Estimation. Levels and trends in child mortality: report 2019. 2019 [Dec 12, 2019]. Available from: https:\/\/www.unicef.org\/reports\/levels-and-trends-child-mortality-report-2019."},{"issue":"10063","key":"10.1016\/j.vaccine.2020.08.052_b0010","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1016\/S0140-6736(16)31593-8","article-title":"Global, regional, and national causes of under-5 mortality in 2000\u201315: an updated systematic analysis with implications for the Sustainable Development Goals","volume":"388","author":"Liu","year":"2016","journal-title":"The Lancet"},{"issue":"9938","key":"10.1016\/j.vaccine.2020.08.052_b0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(14)60496-7","article-title":"Every Newborn: progress, priorities, and potential beyond survival","volume":"384","author":"Lawn","year":"2014","journal-title":"The Lancet"},{"key":"10.1016\/j.vaccine.2020.08.052_b0020","unstructured":"Maternal immunisation. The Lancet Series; 2017."},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.08.052_b0025","article-title":"Maternal Colonization With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses","volume":"65","author":"Russell","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"9724","key":"10.1016\/j.vaccine.2020.08.052_b0030","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(09)61712-8","article-title":"Infection-related stillbirths","volume":"375","author":"Goldenberg","year":"2010","journal-title":"The Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.052_b0035","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/QCO.0b013e328360dc31","article-title":"Genitourinary pathogens and preterm birth","volume":"26","author":"Cunnington","year":"2013","journal-title":"Current Opinion in Infectious Diseases"},{"issue":"9","key":"10.1016\/j.vaccine.2020.08.052_b0040","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005816","article-title":"Membrane Vesicles of Group B Streptococcus Disrupt Feto-Maternal Barrier Leading to Preterm Birth","volume":"12","author":"Surve","year":"2016","journal-title":"PLoS Pathog"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.08.052_b0045","article-title":"Stillbirth With Group B Streptococcus Disease Worldwide: Systematic Review and Meta-analyses","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.08.052_b0050","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix661","article-title":"Preterm Birth Associated With Group B Streptococcus Maternal Colonization Worldwide: Systematic Review and Meta-analyses","volume":"65","author":"Bianchi-Jassir","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.08.052_b0055","article-title":"Estimates of the Burden of Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children","volume":"65","author":"Seale","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2020.08.052_b0060","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1001\/jama.299.17.2056","article-title":"Epidemiology of invasive group B streptococcal disease in the United States, 1999\u20132005","volume":"299","author":"Phares","year":"2008","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.052_b0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1056\/NEJM200001063420103","article-title":"Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis","volume":"342","author":"Schrag","year":"2000","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2020.08.052_b0070","doi-asserted-by":"crossref","first-page":"386","DOI":"10.3109\/23744235.2015.1131330","article-title":"The changing epidemiology of group B streptococcus bloodstream infection: a multi-national population-based assessment","volume":"48","author":"Ballard","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/j.vaccine.2020.08.052_b0075","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1016\/j.vaccine.2012.11.056","article-title":"Intrapartum antibiotic prophylaxis for the prevention of perinatal group B streptococcal disease: Experience in the United States and implications for a potential group B streptococcal vaccine","volume":"31","author":"Schrag","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"10.1016\/j.vaccine.2020.08.052_b0080","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clp.2010.02.002","article-title":"Group B streptococcal disease in infants: progress in prevention and continued challenges","volume":"37","author":"Verani","year":"2010","journal-title":"Clin Perinatol"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.08.052_b0085","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix654","article-title":"Intrapartum Antibiotic Chemoprophylaxis Policies for the Prevention of Group B Streptococcal Disease Worldwide: Systematic Review","volume":"65","author":"Le Doare","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2020.08.052_b0090","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1093\/cid\/cix666","article-title":"Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy","volume":"65","author":"Madhi","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.vaccine.2020.08.052_b0095","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1021\/acschembio.5b00247","article-title":"Anti-Group B Streptococcus Glycan-Conjugate Vaccines Using Pilus Protein GBS80 As Carrier and Antigen: Comparing Lysine and Tyrosine-directed Conjugation","volume":"10","author":"Nilo","year":"2015","journal-title":"ACS Chem Biol"},{"issue":"14","key":"10.1016\/j.vaccine.2020.08.052_b0100","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJM197604012941404","article-title":"Correlation of maternal antibody deficiency with susceptibility to neonatal group B streptococcal infection","volume":"294","author":"Baker","year":"1976","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.vaccine.2020.08.052_b0105","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/S1473-3099(16)00152-3","article-title":"Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b\/2 trial","volume":"16","author":"Madhi","year":"2016","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2020.08.052_b0110","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.1093\/infdis\/jis605","article-title":"Capsular switching in group B Streptococcus CC17 hypervirulent clone: a future challenge for polysaccharide vaccine development","volume":"206","author":"Bellais","year":"2012","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.052_b0115","doi-asserted-by":"crossref","first-page":"76","DOI":"10.7774\/cevr.2018.7.1.76","article-title":"Status of group B streptococcal vaccine development","volume":"7","author":"Lin","year":"2018","journal-title":"Clin Exper Vacc Res"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.052_b0120","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1128\/JCM.41.6.2530-2536.2003","article-title":"Multilocus sequence typing system for group B streptococcus","volume":"41","author":"Jones","year":"2003","journal-title":"J Clin Microbiol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.052_b0125","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ijmm.2018.10.005","article-title":"Molecular epidemiology of invasive and non-invasive group B Streptococcus circulating in Serbia","volume":"309","author":"Gajic","year":"2019","journal-title":"Int J Med Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.08.052_b0130","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1128\/JCM.01182-07","article-title":"Analysis of group B streptococcal isolates from infants and pregnant women in Portugal revealing two lineages with enhanced invasiveness","volume":"45","author":"Martins","year":"2007","journal-title":"J Clin Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.08.052_b0135","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.3201\/eid1410.080185","article-title":"Invasive group B streptococcal infections in infants","volume":"14","author":"Poyart","year":"2008","journal-title":"France Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.052_b0140","doi-asserted-by":"crossref","unstructured":"Bjornsdottir ES, Martins ER, Erlendsdottir H, Haraldsson G, Melo-Cristino J, Kristinsson KG, et al. Changing epidemiology of group B streptococcal infections among adults in Iceland: 1975-2014. Clin Microbiol Infect. 2016;22(4):379.e9-.e16.","DOI":"10.1016\/j.cmi.2015.11.020"},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.052_b0145","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1128\/JCM.01424-08","article-title":"Multilocus sequence types associated with neonatal group B streptococcal sepsis and meningitis in Canada","volume":"47","author":"Manning","year":"2009","journal-title":"J Clin Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2020.08.052_b0150","doi-asserted-by":"crossref","first-page":"3727","DOI":"10.1128\/JCM.43.8.3727-3733.2005","article-title":"Multilocus sequence typing of Swedish invasive group B streptococcus isolates indicates a neonatally associated genetic lineage and capsule switching","volume":"43","author":"Luan","year":"2005","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2020.08.052_b0155","first-page":"2669","article-title":"Progress toward a group B streptococcal vaccine","volume":"14","author":"Song","year":"2018","journal-title":"Hum Vacc Immunotherapeutics"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.052_b0160","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1007\/s10096-015-2342-9","article-title":"Distribution of pilus islands and alpha-like protein genes of group B Streptococcus colonized in pregnant women in Beijing, China","volume":"34","author":"Lu","year":"2015","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.052_b0165","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.diagmicrobio.2016.08.023","article-title":"Molecular characteristics and antimicrobial resistance in invasive and noninvasive Group B Streptococcus between 2008 and 2015 in China","volume":"86","author":"Lu","year":"2016","journal-title":"Diagn Microbiol Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.052_b0170","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000362368","article-title":"Multilocus sequence types of invasive and colonizing neonatal group B streptococci in Poland","volume":"23","author":"Brzychczy-Wloch","year":"2014","journal-title":"Med Princ Pract"},{"issue":"9","key":"10.1016\/j.vaccine.2020.08.052_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2017.02.029","article-title":"Group B streptococcal colonization and transmission dynamics in pregnant women and their newborns in Nigeria: implications for prevention strategies","volume":"23","author":"Medugu","year":"2017","journal-title":"Clin Microbiol Infect"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.08.052_b0180","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix653","article-title":"Group B Streptococcal Disease Worldwide for Pregnant Women, Stillbirths, and Children: Why, What, and How to Undertake Estimates?","volume":"65","author":"Lawn","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.08.052_b0185","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix656","article-title":"Infant Group B Streptococcal Disease Incidence and Serotypes Worldwide: Systematic Review and Meta-analyses","volume":"65","author":"Madrid","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"suppl_2","key":"10.1016\/j.vaccine.2020.08.052_b0190","doi-asserted-by":"crossref","DOI":"10.1093\/cid\/cix660","article-title":"Maternal Disease With Group B Streptococcus and Serotype Distribution Worldwide: Systematic Review and Meta-analyses","volume":"65","author":"Hall","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"49","key":"10.1016\/j.vaccine.2020.08.052_b0195","doi-asserted-by":"crossref","first-page":"6057","DOI":"10.1016\/j.vaccine.2016.03.044","article-title":"Stillbirth: Case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data","volume":"34","author":"Tavares Da Silva","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.052_b0200","unstructured":"UNSTATS. Methodology: Standard Country or Area Codes for Statistical Use: United Nations Statistics Division, Department of Economic and Social Affairs; 2018 [Dec 12, 2019]. Available from: https:\/\/unstats.un.org\/unsd\/methodology\/m49."},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.052_b0205","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.vaccine.2020.08.052_b0210","doi-asserted-by":"crossref","unstructured":"Cho H-K, Na Nam H, Cho H-J, Son D, Kyun Cho Y, Seo Y-H, et al. Serotype Distribution of Invasive Group B Streptococcal Diseases in Infants at Two University Hospitals in Korea. 2017. 79-86 p.","DOI":"10.14776\/piv.2017.24.2.79"},{"key":"10.1016\/j.vaccine.2020.08.052_b0215","article-title":"Serotype distribution and clinical correlation of Streptococcus agalactiae causing invasive disease in infants and children in Taiwan","author":"Lo","year":"2017","journal-title":"J Microbiol Immunol Infect"},{"issue":"11","key":"10.1016\/j.vaccine.2020.08.052_b0220","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1099\/jmm.0.000849","article-title":"Microbiological and clinical characteristics of Group B Streptococcus isolates causing materno-neonatal infections: high prevalence of CC17\/PI-1 and PI-2b sublineage in neonatal infections","volume":"67","author":"Lu","year":"2018","journal-title":"J Med Microbiol"},{"issue":"10","key":"10.1016\/j.vaccine.2020.08.052_b0225","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1097\/01.inf.0000237821.65559.08","article-title":"Serotypes, genotypes, and antibiotic susceptibility profiles of group B streptococci causing neonatal sepsis and meningitis before and after introduction of antibiotic prophylaxis","volume":"25","author":"Trijbels-Smeulders","year":"2006","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.052_b0230","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1128\/JCM.02177-15","article-title":"Molecular Characterization of Nonhemolytic and Nonpigmented Group B Streptococci Responsible for Human Invasive Infections","volume":"54","author":"Six","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.08.052_b0235","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/427942","article-title":"Serotype distribution of invasive group B streptococcal isolates in infants: results from a nationwide active laboratory surveillance study over 2 years in Germany","volume":"40","author":"Fluegge","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.052_b0240","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s12884-017-1419-0","article-title":"Carriage and serotype distribution of Streptococcus agalactiae in third trimester pregnancy in southern Ghana","volume":"17","author":"Slotved","year":"2017","journal-title":"BMC Pregnancy & Childbirth"},{"issue":"7","key":"10.1016\/j.vaccine.2020.08.052_b0245","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s10096-014-2055-5","article-title":"Molecular epidemiology of group B streptococci in Ireland reveals a diverse population with evidence of capsular switching","volume":"33","author":"Meehan","year":"2014","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"10","key":"10.1016\/j.vaccine.2020.08.052_b0250","doi-asserted-by":"crossref","first-page":"e242","DOI":"10.1097\/INF.0000000000001531","article-title":"Genotype Characterization of Group B Streptococcus Isolated From Infants With Invasive Diseases in South Korea","volume":"36","author":"Kang","year":"2017","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.052_b0255","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1097\/INF.0000000000002214","article-title":"Group B Streptococcal Neonatal and Early Infancy Infections in Iceland, 1976\u20132015","volume":"38","author":"Bj\u00f6rnsd\u00f3ttir","year":"2019","journal-title":"Pediatr Infect Dis J"},{"issue":"20","key":"10.1016\/j.vaccine.2020.08.052_b0260","doi-asserted-by":"crossref","first-page":"3354","DOI":"10.1128\/JB.00429-15","article-title":"Whole-Genome Comparison Uncovers Genomic Mutations between Group B Streptococci Sampled from Infected Newborns and Their Mothers","volume":"197","author":"Almeida","year":"2015","journal-title":"J Bacteriol"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.052_b0265","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191193","article-title":"Invasive bacterial disease trends and characterization of group B streptococcal isolates among young infants in southern Mozambique, 2001\u20132015","volume":"13","author":"Siga\u00faque","year":"2018","journal-title":"PLoS ONE"},{"issue":"12","key":"10.1016\/j.vaccine.2020.08.052_b0270","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1469-0691.2009.02789.x","article-title":"Molecular and phenotypic characterization of invasive group B streptococcus strains from infants in Norway 2006\u20132007","volume":"15","author":"Bergseng","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.vaccine.2020.08.052_b0275","doi-asserted-by":"crossref","unstructured":"Nanduri SA, Petit S, Smelser C, Apostol M, Alden NB, Harrison LH, et al. Epidemiology of Invasive Early-Onset and Late-Onset Group B Streptococcal Disease in the United States, 2006 to 2015: Multistate Laboratory and Population-Based Surveillance. JAMA Pediatr. 2019.","DOI":"10.1001\/jamapediatrics.2018.4826"},{"issue":"7","key":"10.1016\/j.vaccine.2020.08.052_b0280","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1086\/500324","article-title":"Enhanced invasiveness of bovine-derived neonatal sequence type 17 group B streptococcus is independent of capsular serotype","volume":"42","author":"Jones","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.052_b0285","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12866-019-1551-2","article-title":"Phenotypic and genetic differences among group B Streptococcus recovered from neonates and pregnant women in Shenzhen, China: 8-year study","volume":"19","author":"Wu","year":"2019","journal-title":"BMC Microbiol"},{"issue":"5","key":"10.1016\/j.vaccine.2020.08.052_b0290","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1128\/JCM.03554-13","article-title":"Characterization of invasive group B streptococcus strains from the greater Toronto area","volume":"52","author":"Teatero","year":"2014","journal-title":"Canada J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.052_b0295","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3389\/fmicb.2016.01265","article-title":"Genomic Analysis Reveals Multi-Drug Resistance Clusters in Group B Streptococcus CC17 Hypervirulent Isolates Causing Neonatal Invasive Disease in Southern Mainland China","volume":"7","author":"Campisi","year":"2016","journal-title":"Front Microbiol"},{"issue":"16","key":"10.1016\/j.vaccine.2020.08.052_b0300","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1017\/S0950268817002461","article-title":"Emergence of the L phenotype in Group B Streptococci in the South of Ireland","volume":"145","author":"Hayes","year":"2017","journal-title":"Epidemiol Infect"},{"issue":"5","key":"10.1016\/j.vaccine.2020.08.052_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0196925","article-title":"Streptococcus agalactiae carriage among pregnant women living in Rio de Janeiro, Brazil, over a period of eight years","volume":"13","author":"Botelho","year":"2018","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.052_b0310","doi-asserted-by":"crossref","first-page":"121","DOI":"10.11150\/kansenshogakuzasshi1970.77.121","article-title":"Serotypes and antibody levels of group B streptococci in pregnant women","volume":"77","author":"Terakubo","year":"2003","journal-title":"Kansenshogaku Zasshi"},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.052_b0315","first-page":"230","article-title":"Serotype Distribution and Antimicrobial Susceptibility Profiles of Group B Streptococcus Strains from Pregnant Women in Beijing, 1994\u201399","volume":"5","author":"Shen","year":"2000","journal-title":"Prenatal Neonatal Med"},{"issue":"12","key":"10.1016\/j.vaccine.2020.08.052_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0169101","article-title":"Temporal Changes in Invasive Group B Streptococcus Serotypes: Implications for Vaccine Development","volume":"11","author":"Dangor","year":"2016","journal-title":"PLoS ONE"},{"issue":"7","key":"10.1016\/j.vaccine.2020.08.052_b0325","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1128\/JCM.00355-16","article-title":"Epidemiology of Invasive Group B Streptococcal Disease in Alberta, Canada, from 2003 to 2013","volume":"54","author":"Alhhazmi","year":"2016","journal-title":"J Clin Microbiol"},{"issue":"9","key":"10.1016\/j.vaccine.2020.08.052_b0330","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1097\/00006454-200109000-00011","article-title":"Population-based active surveillance for neonatal group B streptococcal infections in Alberta, Canada: implications for vaccine formulation","volume":"20","author":"Davies","year":"2001","journal-title":"Pediatr Infect Dis J"},{"issue":"10018","key":"10.1016\/j.vaccine.2020.08.052_b0335","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(15)00837-5","article-title":"Stillbirths: rates, risk factors, and acceleration towards 2030","volume":"387","author":"Lawn","year":"2016","journal-title":"The Lancet"},{"issue":"7","key":"10.1016\/j.vaccine.2020.08.052_b0340","doi-asserted-by":"crossref","first-page":"16067","DOI":"10.1038\/nmicrobiol.2016.67","article-title":"Maternal colonization with Streptococcus agalactiae and associated stillbirth and neonatal disease in coastal Kenya","volume":"1","author":"Seale","year":"2016","journal-title":"Nat Microbiol"},{"issue":"21","key":"10.1016\/j.vaccine.2020.08.052_b0345","doi-asserted-by":"crossref","first-page":"1700473","DOI":"10.2807\/1560-7917.ES.2018.23.21.1700473","article-title":"Increasing macrolide resistance among Streptococcus agalactiae causing invasive disease in non-pregnant adults was driven by a single capsular-transformed lineage, Portugal, 2009 to 2015","volume":"23","author":"Lopes","year":"2018","journal-title":"Eurosurveillance"},{"issue":"9807","key":"10.1016\/j.vaccine.2020.08.052_b0350","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/S0140-6736(10)62225-8","article-title":"Serotype replacement in disease after pneumococcal vaccination","volume":"378","author":"Weinberger","year":"2011","journal-title":"Lancet (London, England)"},{"issue":"2","key":"10.1016\/j.vaccine.2020.08.052_b0355","doi-asserted-by":"crossref","first-page":"155","DOI":"10.11150\/kansenshogakuzasshi.85.155","article-title":"Antimicrobial Susceptibility and Serotype Distribution in Perinatal Group B Streptococcus Isolates -A 1999\u20132009 Multicenter Study-","volume":"85","author":"Wakimoto","year":"2011","journal-title":"Kansenshogaku Zasshi"},{"key":"10.1016\/j.vaccine.2020.08.052_b0360","first-page":"158","article-title":"Active Screening of Group B Streptococci with Reduced Penicillin Susceptibility and Altered Serotype Distribution Isolated from Pregnant Women in Kobe","author":"Kimura","year":"2013","journal-title":"Japan"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.052_b0365","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1086\/342411","article-title":"Seroepidemiologic Studies of Serotype VIII Group B Streptococcus in Japan","volume":"186","author":"Matsubara","year":"2002","journal-title":"J Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2020.08.052_b0370","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jiac.2014.08.024","article-title":"Direct identification of Streptococcus agalactiae and capsular type by real-time PCR in vaginal swabs from pregnant women","volume":"21","author":"Morozumi","year":"2015","journal-title":"J Infect Chemotherapy"},{"issue":"6","key":"10.1016\/j.vaccine.2020.08.052_b0375","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1442-200X.2002.01638.x","article-title":"Trend of neonatal group B streptococcal infection during the last 15 years","volume":"44","author":"Hoshina","year":"2002","journal-title":"Pediatr Int"},{"issue":"5","key":"10.1016\/j.vaccine.2020.08.052_b0380","doi-asserted-by":"crossref","first-page":"356","DOI":"10.7883\/yoken.67.356","article-title":"Characteristics of Group B Streptococcus Isolated from Infants with Invasive Infections: A Population-Based Study in Japan","volume":"67","author":"Chang","year":"2014","journal-title":"Japanese J Infect Diseases"},{"key":"10.1016\/j.vaccine.2020.08.052_b0385","unstructured":"Matsubara K, Hoshina K, Suzuki Y. Early-onset and late-onset group B streptococcal disease in Japan: A nationwide surveillance study, 2004-20102013."},{"issue":"4","key":"10.1016\/j.vaccine.2020.08.052_b0390","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1017\/S0950268813001647","article-title":"Associations between capsular serotype, multilocus sequence type, and macrolide resistance in Streptococcus agalactiae isolates from Japanese infants with invasive infections","volume":"142","author":"Morozumi","year":"2013","journal-title":"Epidemiol Infect"},{"issue":"12","key":"10.1016\/j.vaccine.2020.08.052_b0395","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1586\/14760584.2015.1085307","article-title":"Association between maternal Group B Streptococcus surface-protein antibody concentrations and invasive disease in their infants","volume":"14","author":"Dangor","year":"2015","journal-title":"Expert Rev Vacc"},{"issue":"3","key":"10.1016\/j.vaccine.2020.08.052_b0400","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017861","article-title":"Serotype distribution and invasive potential of group B streptococcus isolates causing disease in infants and colonizing maternal-newborn dyads","volume":"6","author":"Madzivhandila","year":"2011","journal-title":"PLoS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20310938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:47:19Z","timestamp":1759402039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20310938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":80,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0264410X20310938"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.052","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic review of Group B Streptococcal capsular types, sequence types and surface proteins as potential vaccine candidates","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}